Kissei Pharmaceutical

Overview

• HeadquartersMatsumoto¹
• Websitewww.kissei.co.jp

See how the biggest companies compare on our leaderboards

Kissei Pharmaceutical is a pharmaceutical company based in Matsumoto, Nagano, Japan. Products discovered or developed by Kissei include: Difelikefalin Fostamatinib (trade name Tavalisse) Linzagolix Mitiglinide (Glufast) Remogliflozin etabonate Silodosin (Urief) Tranilast (Rizaben) In March 2020, Kissei and CG Oncology, Inc.³

Corporate structure

Kissei Pharmaceutical sits at the top of its group. 2 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (1 companies). Each entity in the chart links to its source.

Timeline

1. Aug 9, 1946Founded Founded¹

Calendar

Drug trials and FDA: coming up

1. Mar 31, 2027Phase 3 trial readout expected Phase 3 trial of KPS-0373 in Spinocerebellar Degeneration: primary completion expected Mar 31, 2027 (ClinicalTrials.gov NCT07040137).⁵

Drug trials and FDA: recently

1. Jan 14, 2026Phase 2 trial completed Phase 2 trial of KDT-3594 in Parkinson Disease: primary completion Jan 14, 2026, no results posted yet (ClinicalTrials.gov NCT06722729).⁶

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). Trials from ClinicalTrials.gov, as the sponsor registered them (expected dates are the sponsor's own and often move); approvals and advisory committee meetings from the FDA. The FDA does not publish its decision (PDUFA) dates. The full markets calendar

Stakes it holds

Kissei Pharmaceutical has told the SEC it owns more than 5% of 1 company, latest first (Schedules 13D and 13G).

• CG Oncology, Inc.SC 13G Mar 14, 2024⁷

SEC filer profile

How Kissei Pharmaceutical is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGARKissei Pharmaceutical Co., Ltd.²
• CIK0001532923
• Incorporated inJapan²
• Fiscal year endsMarch 31²
• Business address19-48, Yoshino, Matsumoto-City, Nagano-Prefecture, M0 399-8710²
• Phone81-3-3279-2307²
• On EDGAR sinceOct 18, 2011²
• Filings5 in all: SC 13D/A (2), 3 (1), SC 13D (1), SC 13G (1)²

Links

• Websitewww.kissei.co.jp¹
• WikipediaKissei
• More imagesWikimedia Commons
• WikidataQ11296797
• SEC EDGARCIK 1532923